Titan Pharmaceuticals, Inc

(NASDAQ:TTNP)

Latest On Titan Pharmaceuticals, Inc (TTNP):

Date/Time Type Description Signal Details
2022-12-15 17:03 ESTNewsTitan Pharmaceuticals rises on plans of merger with undisclosed advanced air mobility playerN/A
2022-12-12 20:41 ESTNewsTitan inks licensing deal with Ocular Therapeutix for US regionN/A
2022-06-11 08:56 ESTNewsActivist Investing discloses 9.9% stake in Titan PharmaceuticalsN/A
2022-02-02 09:25 ESTNewsTitan Pharmaceuticals to raise $5.5M in stock and pre-funded warrant offeringN/A
2021-12-21 10:00 ESTNewsTitan Pharma to evaluate strategic alternativesN/A
2021-10-26 03:07 ESTNewsTitan Pharmaceuticals granted development funding from Gates FoundationN/A
2021-10-12 14:10 ESTNewsWarning: TTNP is at high risk of performing badlyN/A
2021-10-06 19:16 ESTNewsTTNP is at high risk of performing badlyN/A
2021-10-01 00:14 ESTNewsWarning: TTNP has been downgraded to Very BearishN/A
2021-07-22 04:31 ESTNewsTitan Pharma reports positive TP-2021 implant results in animal model of chronic pruritusN/A
2021-02-19 00:50 ESTEarnings EstimateAn EPS average of -$0.96 is estimated for the quarter ending on March 31, 2021.Buy
2021-02-19 00:50 ESTAnalyst RatingThe Analyst Target Price has increased from $0.8 to $11.Buy
2021-01-15 16:34 ESTNewsTitan Pharmaceuticals -3% on pricing of $9.7M direct offeringN/A
2020-12-16 13:05 ESTNewsTitan Pharma regains Nasdaq listing complianceN/A
2020-12-02 05:29 ESTNewsTitan Pharmaceuticals announces 1-for-30 reverse stock splitN/A
2020-12-02 05:25 ESTStock SplitA stock split has occured on Dec 1, 2020 with a split factor of 1:30.Neutral
2020-11-26 21:50 ESTFinancialsCompany financials have been released.Neutral
2020-11-21 13:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-18 13:38 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:08 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:23 ESTFinancialsCompany financials have been released.Neutral
2020-11-03 11:25 ESTNewsTitan Pharma closes debt settlement and JT-09 acquisitionN/A
2020-11-01 03:34 ESTNewsTitan Pharmaceuticals to acquire JT Pharma's JT-09N/A
2020-11-01 03:33 ESTNewsTitan Pharma to raise $8M in stock offeringN/A
2020-10-27 03:14 ESTNewsTitan Pharmaceuticals inks agreement to settle its debt with Molteni and HorizonN/A
2020-10-16 03:59 ESTNewsTitan Pharmaceuticals issues strategic and corporate updateN/A
2020-09-26 14:20 ESTFinancialsCompany financials have been released.Neutral
2020-09-25 02:12 ESTNewsTitan Pharma prices $2.7M direct offeringN/A
2020-09-18 19:07 ESTNewsTitan Pharmaceuticals' increases authorized sharesN/A
2020-09-17 06:29 ESTFinancialsCompany financials have been released.Neutral
2020-09-16 02:28 ESTNewsTitan Pharma inks distribution pact with Accord for opioid addiction medN/A
2020-08-18 13:54 ESTAnalyst RatingThe Analyst Target Price has decreased from $1 to $0.8.Neutral
2020-08-17 05:49 ESTFinancialsCompany financials have been released.Neutral
2020-08-17 01:54 ESTEarnings EstimateAn EPS average of -$0.03 is estimated for the quarter ending on September 30, 2020.Buy
2020-08-15 06:43 ESTNewsTitan Pharmaceuticals EPS misses by $0.01, beats on revenueN/A
2020-08-15 06:43 ESTNewsTitan Pharma top-line up 160%N/A
2020-08-15 06:42 ESTNewsTitan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-14 10:24 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 09:46 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 18:09 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:05 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 22:13 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:01 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 18:43 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:14 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 18:00 ESTFinancialsCompany financials have been released.Neutral
2020-06-24 19:10 ESTNewsTitan Pharma teams up with Indegene for co-promotion of ProbuphineN/A
2020-06-19 13:53 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 05:57 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 06:45 ESTFinancialsCompany financials have been released.Neutral

About Titan Pharmaceuticals, Inc (TTNP):

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.

TTNP Quotes by TradingView

See Advanced Chart

General

  • Name Titan Pharmaceuticals, Inc
  • Symbol TTNP
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 21
  • Last Split Factor1:30
  • Last Split Date2020-12-01
  • Fiscal Year EndDecember
  • IPO Date1996-01-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.titanpharm.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 1.83
  • Price/Book (Most Recent Quarter) 14.52
  • Enterprise Value Revenue 6.92
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.02
  • Operating Margin -342%
  • Return on Assets -160%
  • Revenue 5 million
  • Earnings Per Share -$0.93
  • Revenue Per Share $1.85
  • Gross Profit -4919000
  • Quarterly Earnings Growth 18.3%
View More

Highlights

  • Market Capitalization 31.76 million
  • EBITDA -14106000
  • PE Ratio -1.03
  • Analyst Target Price $11
  • Book Value Per Share $0.02
View More

Share Statistics

  • Shares Outstanding 9.86 million
  • Shares Float 5.29 million
  • % Held by Insiders 508%
  • % Held by Institutions 3.53%
  • Shares Short 1.58 million
  • Shares Short Prior Month 1.31 million
  • Short Ratio 0.55
  • Short % of Float 16%
  • Short % of Shares Outstanding 16%
View More

Technicals

  • Beta 0.96
  • 52 Week High $14.06
  • 52 Week Low $2.56
  • 50 Day Moving Average 3.43
  • 200 Day Moving Average 4.05
View More

Dividends

  • Dividend Date 2020-12-01
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Titan Pharmaceuticals, Inc (TTNP) Dividend Calendar:

TTNP's last dividend payment was made to shareholders on December 1, 2020.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Titan Pharmaceuticals, Inc (TTNP) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A-$1.50-$1.05-42.86%
2020-06-302020-08-14$N/A-$1.50-$1.05-42.86%
2020-03-312020-05-15$1.34 million-$2.10
2019-12-312020-03-30$N/A-$2.40-$2.400%
2019-09-302019-11-14$947000-$5.40-$6.4516.28%
2019-06-302019-08-14$502000-$11.40-$7.95-43.4%
2019-03-312019-05-15$945000-$10.20-$7.80-30.77%
2018-12-312018-12-31$1.24 million-$0.29-$0.316.45%
2018-09-302018-11-14$1.65 million-$19.80-$24.3018.52%
2018-06-302018-08-14$2.67 million-$7.20-$27.0073.33%
2018-03-312018-05-15$1.06 million-$21.60-$23.407.69%
2017-09-302017-11-09$40000-$36.00-$25.20-42.86%
2017-06-302017-08-09$77000-$28.80-$24.30-18.52%
2017-03-312017-05-10$40000-$25.20-$27.006.67%
2016-12-312017-03-16$35000-$19.80-$18.00-10%
2016-09-302016-11-09$26000-$21.60-$19.80-9.09%
2016-06-302016-08-09$15 million$99.00$107.10-7.56%
2016-03-312016-05-10$N/A-$16.20-$20.7021.74%
2015-12-312016-03-15$1.67 million-$19.80-$21.608.33%
2015-09-302015-11-16$-760000-$0.09-$0.1118.18%
2015-06-302015-08-13$760000-$0.11-$0.05-120%
2015-03-312015-05-13$911000-$0.22-$0.05-340%
2014-12-312015-03-31$912000-$0.05-$0.050%
2014-09-302014-11-13$911000$0.06-$0.05220%
2014-06-302014-08-13$912000-$0.33-$0.330%
2014-03-312014-05-14$911000-$20.08
2013-09-302013-11-14$2.2 million-$1.62
2013-06-302013-08-15$2.2 million-$3.57
2013-03-312013-05-15$5.17 million$2.31-$0.33800%
2012-12-312013-03-15$3.26 million-$4.15
2012-09-302012-11-12$1.23 million-$118.69
2012-06-302012-08-10$1.36 million-$26.26
2012-03-312012-05-11$1.27 million-$86.07
2011-12-312012-03-20$1.41 million-$48.36
2011-09-302011-11-15$1.01 million-$13.40
2011-06-302011-08-16$695000-$116.73
2011-03-312011-05-16$948000-$75.39
2010-12-312011-03-24$2.73 million-$51.10
2010-09-302010-11-15$3.6 million-$6.42
2010-06-302010-08-16$1.34 million-$30.85
2010-03-312010-05-17$2.43 million-$5.10
2008-12-312009-03-11$73000-$104.07
2008-09-302008-11-10$-12000-$3.30-$3.300%
2008-06-302008-08-11$12000-$4.29-$3.63-18.18%
2008-03-312008-05-12$61000-$3.30-$3.639.09%
2007-12-312008-03-12$12000-$4.62-$3.30-40%
2007-09-302007-11-08$-12000-$3.30-$2.97-11.11%
2007-06-302007-08-02$12000-$2.64-$2.640%
2007-03-312007-05-09$N/A-$2.97-$4.2930.77%
2006-12-312007-03-05$29000-$2.97-$5.2843.75%
2006-09-302006-11-09$1000-$3.63-$2.97-22.22%
2006-06-302006-08-09$1000-$2.97-$4.2930.77%
2006-03-312006-05-08$1000-$4.29-$6.6035%
2005-12-312006-03-14$61000-$3.96-$6.2736.84%
2005-09-302005-11-09$1000-$6.60-$7.5913.04%
2005-06-302005-08-09$13000-$5.94-$5.61-5.88%
2005-03-312005-05-10$14000-$6.27-$6.939.52%
2004-12-312005-03-14$30000-$7.92-$6.60-20%
2004-09-302004-11-09$N/A-$6.60-$8.5823.08%
2004-06-302004-08-09$-1000-$5.61-$7.5926.09%
2004-03-312004-05-06$1000-$7.26-$7.928.33%
2003-12-312004-03-11$61000-$7.92-$7.59-4.35%
2003-09-302003-11-14$-2000-$7.26-$7.928.33%
2003-06-302003-08-11$2000-$7.92-$7.59-4.35%
2003-03-312003-05-15$26000-$7.92-$7.26-9.09%
2002-12-312003-03-27$236000-$10.56-$9.90-6.67%
2002-09-302002-11-14$158000-$8.58-$8.832.83%
2002-06-302002-08-12$151000-$8.25-$8.583.85%
2002-03-312002-05-14$2.35 million-$5.94-$6.021.33%
2001-12-312002-03-28$589000-$7.59-$7.590%
2001-09-302001-11-15$530000-$5.61-$5.691.41%
2001-06-302001-08-15$2.87 million-$2.31-$4.8252.07%
2001-03-312001-05-15$580000-$5.28-$4.70-12.34%
2000-12-312001-03-22$569000-$4.95-$5.204.81%
2000-09-302000-11-14$695000-$4.62-$5.7719.93%
2000-06-302000-08-15$281000-$2.97-$3.3010%
2000-03-312000-05-15$335000-$4.95-$4.29-15.38%
1999-12-312000-03-23-$4.95-$4.07-21.62%
1999-09-301999-11-15-$5.28-$4.62-14.29%
1999-06-301999-08-16-$6.60-$6.10-8.2%
1999-03-311999-05-17-$6.27-$5.94-5.56%
1998-12-311999-03-31-$8.25-$7.09-16.36%
1998-09-301998-12-01-$6.93-$6.930%
1998-06-301998-08-17-$5.61-$8.7435.81%
1998-03-311998-04-01-$10.23-$10.06-1.69%
1997-12-311998-03-31-$10.23-$10.06-1.69%

Titan Pharmaceuticals, Inc (TTNP) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A 2.28 million N/A 1.62 million
Income Before Tax N/A N/A -5.58 million N/A -2.8 million
Selling General Administrative N/A N/A 3.11 million N/A 3.02 million
Gross Profit N/A N/A 1.17 million N/A 759000
Ebit N/A N/A -5.3 million N/A -3.88 million
Operating Income N/A N/A -4.23 million N/A -3.88 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A 1.34 million N/A 947000
Cost of Revenue N/A N/A 171000 N/A 188000
Total Other Income Expense Net N/A N/A -1.14 million N/A 1.08 million
Net Income From Continuing Operations N/A N/A -5.58 million N/A -2.8 million
Net Income Applicable to Common Shares -4.93 million -4.64 million N/A -3.94 million -2.8 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A -30000 N/A N/A
Change to Liabilities 560000 191000 N/A -14000 390000
Total Cash Flow from Investing Activities -444000 -57000 N/A -112000 -61000
Net Borrowings N/A 654000 N/A N/A N/A
Total Cash Flow from Financial Activities 2.47 million N/A 8.06 million N/A 2.02 million
Change to Operating Activities N/A -405000 N/A 778000 -220000
Change in Cash -1.43 million N/A 2.82 million N/A -1.37 million
Total Cash from Operating Activities -3.45 million -3.98 million -5.21 million -3.66 million -3.33 million
Depreciation 99000 N/A 62000 N/A 63000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory -537000 N/A -66000 N/A 55000
Change to Account Receivables N/A N/A -558000 N/A 266000
Other Cash Flow from Financing Activities 2.44 million N/A N/A N/A N/A
Change to Net Income 588000 221000 N/A 55000 -1.08 million
Capital Expenditures 444000 N/A 30000 N/A 61000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A N/A 7.99 million N/A 7.96 million
Total Stockholder Equity N/A N/A 5.28 million N/A -2.66 million
Other Current Liabilities 5.88 million N/A N/A N/A N/A
Total Assets N/A N/A 13.26 million N/A 5.3 million
Common Stock -897000 97000 N/A 57000 17000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings N/A -359.26 million -354.62 million -349.04 million -345.1 million
Other Liabilities N/A N/A N/A 320000 388000
Other Assets N/A N/A N/A N/A 150000
Cash N/A N/A 8.04 million N/A 921000
Total Current Liabilities 5.88 million N/A 4.41 million N/A 3.48 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 1.37 million 1.07 million N/A 1.21 million 1.21 million
Total Current Assets 6.65 million N/A 12.15 million N/A 3.95 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets -897000 1.56 million N/A 1.43 million -2.66 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A 3.5 million N/A 3.87 million
Inventory 1.07 million N/A 1.06 million N/A 1.31 million
Accounts Payable N/A N/A 1.33 million N/A 1.38 million

Titan Pharmaceuticals, Inc (TTNP) Chart:

Titan Pharmaceuticals, Inc (TTNP) News:

Below you will find a list of latest news for Titan Pharmaceuticals, Inc (TTNP) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Titan Pharmaceuticals, Inc (TTNP) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest TTNP Trades:

Date Shares Price
Jun 13, 2022 6:50 PM EST100$0.52
Jun 13, 2022 7:04 PM EST100$0.5099

Titan Pharmaceuticals, Inc (TTNP) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920078070/0001104659-20-078070-index.htm
2018-08-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/910267/000000000018025963/0000000000-18-025963-index.htm
2019-04-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/910267/000000000019007162/0000000000-19-007162-index.htm
2019-09-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/910267/000000000019013620/0000000000-19-013620-index.htm
2019-10-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/910267/000090266419004033/0000902664-19-004033-index.htm
2020-01-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/910267/000090266420000479/0000902664-20-000479-index.htm
2019-10-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/910267/000110465919054586/0001104659-19-054586-index.htm
2019-10-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465919054978/0001104659-19-054978-index.htm
2019-11-04PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000110465919059094/0001104659-19-059094-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/910267/000110465919064166/0001104659-19-064166-index.htm
2019-11-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000110465919065596/0001104659-19-065596-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465919071378/0001104659-19-071378-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465919075090/0001104659-19-075090-index.htm
2019-12-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465919075465/0001104659-19-075465-index.htm
2019-12-31DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465919076943/0001104659-19-076943-index.htm
2020-01-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/910267/000110465920002003/0001104659-20-002003-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920002040/0001104659-20-002040-index.htm
2020-01-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/910267/000110465920002046/0001104659-20-002046-index.htm
2020-01-09DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/910267/000110465920002692/0001104659-20-002692-index.htm
2020-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920004815/0001104659-20-004815-index.htm
2020-01-21PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000110465920005614/0001104659-20-005614-index.htm
2020-01-31DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000110465920009232/0001104659-20-009232-index.htm
2020-01-31DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920009315/0001104659-20-009315-index.htm
2020-02-12DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920017539/0001104659-20-017539-index.htm
2020-02-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920022657/0001104659-20-022657-index.htm
2020-02-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920024286/0001104659-20-024286-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920027674/0001104659-20-027674-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920034140/0001104659-20-034140-index.htm
2020-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920035935/0001104659-20-035935-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/910267/000110465920040354/0001104659-20-040354-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920051001/0001104659-20-051001-index.htm
2020-05-12PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000110465920060233/0001104659-20-060233-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/910267/000110465920062136/0001104659-20-062136-index.htm
2020-05-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000110465920065484/0001104659-20-065484-index.htm
2020-06-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920074741/0001104659-20-074741-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920076573/0001104659-20-076573-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920078066/0001104659-20-078066-index.htm
2020-06-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920078070/0001104659-20-078070-index.htm
2020-07-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920082100/0001104659-20-082100-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920084040/0001104659-20-084040-index.htm
2020-07-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920084041/0001104659-20-084041-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920090511/0001104659-20-090511-index.htm
2020-08-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920090512/0001104659-20-090512-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920093801/0001104659-20-093801-index.htm
2020-08-12DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920093802/0001104659-20-093802-index.htm
2020-08-138-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920094278/0001104659-20-094278-index.htm
2020-08-13DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920094279/0001104659-20-094279-index.htm
2020-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/910267/000110465920095091/0001104659-20-095091-index.htm
2020-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920096969/0001104659-20-096969-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920100978/0001104659-20-100978-index.htm
2020-09-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920100979/0001104659-20-100979-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920104869/0001104659-20-104869-index.htm
2020-09-14DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/910267/000110465920104870/0001104659-20-104870-index.htm
2020-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920106533/0001104659-20-106533-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920108367/0001104659-20-108367-index.htm
2020-09-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/910267/000110465920108489/0001104659-20-108489-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920115280/0001104659-20-115280-index.htm
2020-10-19S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000110465920116128/0001104659-20-116128-index.htm
2020-10-23PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000110465920117763/0001104659-20-117763-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920117956/0001104659-20-117956-index.htm
2020-10-26S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000110465920117957/0001104659-20-117957-index.htm
2020-10-27S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000110465920118552/0001104659-20-118552-index.htm
2020-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920118991/0001104659-20-118991-index.htm
2020-10-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/910267/000110465920119567/0001104659-20-119567-index.htm
2020-11-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000110465920120516/0001104659-20-120516-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000110465920120526/0001104659-20-120526-index.htm
2018-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418029218/0001144204-18-029218-index.htm
2018-05-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420418030506/0001144204-18-030506-index.htm
2018-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418031721/0001144204-18-031721-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418032382/0001144204-18-032382-index.htm
2018-07-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000114420418036970/0001144204-18-036970-index.htm
2018-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418041056/0001144204-18-041056-index.htm
2018-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418041882/0001144204-18-041882-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418042773/0001144204-18-042773-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/910267/000114420418044671/0001144204-18-044671-index.htm
2018-08-14S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000114420418044769/0001144204-18-044769-index.htm
2018-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418045343/0001144204-18-045343-index.htm
2018-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418047697/0001144204-18-047697-index.htm
2018-09-04FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/910267/000114420418047698/0001144204-18-047698-index.htm
2018-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418048734/0001144204-18-048734-index.htm
2018-09-10FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/910267/000114420418048736/0001144204-18-048736-index.htm
2018-09-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000114420418049103/0001144204-18-049103-index.htm
2018-09-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420418049988/0001144204-18-049988-index.htm
2018-09-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420418049990/0001144204-18-049990-index.htm
2018-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418050015/0001144204-18-050015-index.htm
2018-09-20S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000114420418050033/0001144204-18-050033-index.htm
2018-09-25424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/910267/000114420418050585/0001144204-18-050585-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418050743/0001144204-18-050743-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420418050778/0001144204-18-050778-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420418050779/0001144204-18-050779-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420418050780/0001144204-18-050780-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420418050781/0001144204-18-050781-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420418050782/0001144204-18-050782-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420418050965/0001144204-18-050965-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418052332/0001144204-18-052332-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420418054751/0001144204-18-054751-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420418054795/0001144204-18-054795-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/910267/000114420418059914/0001144204-18-059914-index.htm
2018-12-06PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000114420418063197/0001144204-18-063197-index.htm
2018-12-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/910267/000114420418065476/0001144204-18-065476-index.htm
2019-01-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420419002680/0001144204-19-002680-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420419007517/0001144204-19-007517-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420419009816/0001144204-19-009816-index.htm
2019-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420419009921/0001144204-19-009921-index.htm
2019-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420419009923/0001144204-19-009923-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/910267/000114420419017459/0001144204-19-017459-index.htm
2019-04-0210-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/910267/000114420419017559/0001144204-19-017559-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420419018017/0001144204-19-018017-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420419018018/0001144204-19-018018-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420419018020/0001144204-19-018020-index.htm
2019-04-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000114420419018434/0001144204-19-018434-index.htm
2019-04-16S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000114420419019741/0001144204-19-019741-index.htm
2019-04-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419020775/0001144204-19-020775-index.htm
2019-04-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420419021361/0001144204-19-021361-index.htm
2019-04-26424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/910267/000114420419021363/0001144204-19-021363-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/910267/000114420419026546/0001144204-19-026546-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420419030297/0001144204-19-030297-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420419032717/0001144204-19-032717-index.htm
2019-08-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/910267/000114420419038607/0001144204-19-038607-index.htm
2019-08-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/910267/000114420419038634/0001144204-19-038634-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420419038636/0001144204-19-038636-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/910267/000114420419040066/0001144204-19-040066-index.htm
2019-08-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/910267/000114420419040674/0001144204-19-040674-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420419041326/0001144204-19-041326-index.htm
2019-09-12S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000114420419044334/0001144204-19-044334-index.htm
2019-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420419045089/0001144204-19-045089-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/910267/000114420419045386/0001144204-19-045386-index.htm
2019-09-27S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000114420419046325/0001144204-19-046325-index.htm
2019-10-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419046785/0001144204-19-046785-index.htm
2019-10-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419046871/0001144204-19-046871-index.htm
2019-10-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419047153/0001144204-19-047153-index.htm
2019-10-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419047383/0001144204-19-047383-index.htm
2019-10-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419047407/0001144204-19-047407-index.htm
2019-10-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419047521/0001144204-19-047521-index.htm
2019-10-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000114420419047699/0001144204-19-047699-index.htm
2019-10-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419047811/0001144204-19-047811-index.htm
2019-10-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419047814/0001144204-19-047814-index.htm
2019-10-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419047954/0001144204-19-047954-index.htm
2019-10-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419048047/0001144204-19-048047-index.htm
2019-10-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419048049/0001144204-19-048049-index.htm
2019-10-11S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000114420419048088/0001144204-19-048088-index.htm
2019-10-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419048091/0001144204-19-048091-index.htm
2019-10-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419048102/0001144204-19-048102-index.htm
2019-10-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/910267/000114420419048103/0001144204-19-048103-index.htm
2019-08-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/910267/000153561019000094/0001535610-19-000094-index.htm
2020-01-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/910267/000153561020000030/0001535610-20-000030-index.htm
2020-09-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/910267/000153561020000113/0001535610-20-000113-index.htm
2020-10-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/910267/000155335020000907/0001553350-20-000907-index.htm
2018-08-30S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/910267/000157104918000460/0001571049-18-000460-index.htm
2018-09-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/910267/000157104918000485/0001571049-18-000485-index.htm
2018-09-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/910267/999999999518002418/9999999995-18-002418-index.htm
2019-04-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/910267/999999999519000814/9999999995-19-000814-index.htm
2019-10-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/910267/999999999519002323/9999999995-19-002323-index.htm
2020-10-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/910267/999999999520003013/9999999995-20-003013-index.htm
2018-06-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/910267/999999999718006406/9999999997-18-006406-index.htm
2018-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/910267/999999999718007779/9999999997-18-007779-index.htm
2018-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/910267/999999999718007780/9999999997-18-007780-index.htm
2019-09-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/910267/999999999719006921/9999999997-19-006921-index.htm

Titan Pharmaceuticals, Inc (TTNP) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Titan Pharmaceuticals, Inc (TTNP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 508%
Institutional Ownership: 353%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-09-21M DAVID MACFARLANEDirectorBuy80,000.000.2520,000.00102,275.00https://www.sec.gov/Archives/edgar/data/910267/000114420418050782/0001144204-18-050782-index.htm
2018-09-21Joseph A AkersDirectorBuy200,000.000.2550,000.00213,000.00https://www.sec.gov/Archives/edgar/data/910267/000114420418050778/0001144204-18-050778-index.htm
2018-09-21JAMES R MCNABDirectorBuy200,000.000.2550,000.00300,000.00https://www.sec.gov/Archives/edgar/data/910267/000114420418050780/0001144204-18-050780-index.htm
2018-09-21SUNIL BHONSLEOfficerBuy300,000.000.2575,000.00435,578.00https://www.sec.gov/Archives/edgar/data/910267/000114420418050781/0001144204-18-050781-index.htm
2018-09-21Marc RubinExecutive ChairmanBuy400,000.000.25100,000.00556,317.00https://www.sec.gov/Archives/edgar/data/910267/000114420418050779/0001144204-18-050779-index.htm
2018-09-24Federico Seghi RecliDirectorBuy500,000.00600,845.00https://www.sec.gov/Archives/edgar/data/910267/000114420418050965/0001144204-18-050965-index.htm
2018-10-19Federico Seghi RecliDirectorBuy200,000.00800,845.00https://www.sec.gov/Archives/edgar/data/910267/000114420418054751/0001144204-18-054751-index.htm